foxo4-dri senolytic peptide mouse study 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications How to plan a self experiment with senolytic peptide foxo4 dri Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI 2460055 10 9 AdooQ
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14


